{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:03:43Z","timestamp":1787061823175,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch National Health Council Grant","award":["10430072110007"],"award-info":[{"award-number":["10430072110007"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>An upsurge in pediatric invasive group A streptococcal infection (iGAS) has been observed in the Netherlands along with a suspected increase in iGAS-related sudden death. Sudden unexplained deaths in youth (SUDY) are investigated nationally through a standardized procedure [(Postmortem Evaluation of Sudden Unexplained Death in Youth (PESUDY)]. We investigate epidemiological differences between pediatric iGAS-related sudden deaths (iGAS-PESUDY) and surviving iGAS cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This observational study used data from the COPP-iGAS study on pediatric iGAS infections in Dutch hospitals and the PESUDY database. Children 0\u201318 years of age were included between August 2016 and December 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-one iGAS-PESUDY cases and 156 iGAS survivors were included. iGAS-PESUDY cases tended to be older compared to survivors. iGAS-PESUDY cases significantly increased in 2022 compared to the pre-COVID period. Pre- and\/or coinciding infections were present in 66% of iGAS-PESUDY cases, predominantly varicella zoster (19%) and influenza (24%). In survivors, 13% had varicella zoster virus and 3% had influenza virus (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 0.001). C-reactive protein levels tended to be lower in iGAS-PESUDY cases (81\u2009mg\/L; interquartile range, 26.8\u2013307.5) compared to survivors (266\u2009mg\/L; interquartile range, 218.0\u2013302.0).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>iGAS is currently a prevalent cause of SUDY. The finding of moderately elevated C-reactive protein levels compared to high levels in survivors might suggest children dying suddenly of iGAS have a rapid and fulminant disease course. Children with a pre- and\/or coinciding infection of varicella zoster or influenza virus may be at greater risk of succumbing to iGAS infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004775","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T15:01:42Z","timestamp":1741618902000},"page":"e156-e160","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Group A Streptococcal Disease in Sudden Unexpected Death in Youth in the Pre- and Post-COVID-19 Era"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7416-795X","authenticated-orcid":false,"given":"Evelien B.","family":"van Kempen","sequence":"first","affiliation":[{"name":"Department of Paediatrics, ErasmusMC Sophia Children\u2019s Hospital, Rotterdam, the Netherlands"},{"name":"Department of Paediatrics, Juliana Children\u2019s Hospital Haga Hospital, the Hague, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelotte M.","family":"Pries","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, ErasmusMC Sophia Children\u2019s Hospital, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline P.","family":"Buddingh","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Willem-Alexander Children\u2019s Hospital Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja J.","family":"Puiman","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, ErasmusMC Sophia Children\u2019s Hospital, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"van Veen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Juliana Children\u2019s Hospital Haga Hospital, the Hague, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of PESUDY collaborative and COPP-IGAS collaborative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"R1-20250514","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1097\/INF.0000000000003810","article-title":"Increase in invasive group a streptococcal infections in children in the Netherlands, a survey among 7 hospitals in 2022.","volume":"42","author":"van Kempen","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R2-20250514","article-title":"Increased incidence of scarlet fever and invasive Group A Streptococcus infection - multi-country: WHO; 2022."},{"issue":"Suppl 2","key":"R3-20250514","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S0929-693X(14)72262-6","article-title":"[Epidemiology of Streptococcus pyogenes invasive diseases in France (2007-2011)].","volume":"21","author":"Plainvert","year":"2014","journal-title":"Arch Pediatr"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"19780","DOI":"10.2807\/ese.16.05.19780-en","article-title":"Group A streptococcal infections during the seasonal influenza outbreak 2010\/11 in South East England.","volume":"16","author":"Scaber","year":"2011","journal-title":"Euro Surveill"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-022-04718-y","article-title":"Group A streptococcal disease in paediatric inpatients: a European perspective.","volume":"182","author":"Boeddha","year":"2023","journal-title":"Eur J Pediatr"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2352-4642(23)00295-X","article-title":"Invasive group A streptococcal infections in children and adolescents in Denmark during 2022-23 compared with 2016-17 to 2021-22: a nationwide, multicentre, population-based cohort study.","volume":"8","author":"Nygaard","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"R7-20250514","doi-asserted-by":"crossref","first-page":"2200942","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200942","article-title":"Increase in invasive group A streptococcal infection notifications, England, 2022.","volume":"28","author":"Guy","year":"2023","journal-title":"Euro Surveill"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?","volume":"51","author":"Cohen","year":"2021","journal-title":"Infect Dis Now"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"2200941","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200941","article-title":"Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022.","volume":"28","author":"de Gier","year":"2023","journal-title":"Euro Surveill"},{"key":"R10-20250514","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1473-3099(20)30278-4","article-title":"Dominance of M1(UK) clade among Dutch M1 Streptococcus pyogenes.","volume":"20","author":"R\u00fcmke","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R12-20250514","doi-asserted-by":"crossref","first-page":"113780","DOI":"10.1016\/j.jpeds.2023.113780","article-title":"A systematic approach to evaluate sudden unexplained death in children.","volume":"264","author":"Pries","year":"2024","journal-title":"J Pediatr"},{"key":"R13-20250514","article-title":"COPP-iGAS Study."},{"key":"R14-20250514","doi-asserted-by":"crossref","first-page":"2300427","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300427","article-title":"Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1(UK) and diverse emm12 isolates, Portugal, September 2022 to May 2023.","volume":"28","author":"Gouveia","year":"2023","journal-title":"Euro Surveill"},{"key":"R15-20250514","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1574-695X.1999.tb01327.x","article-title":"Microbiology in sudden infant death syndrome (SIDS) and other childhood deaths.","volume":"25","author":"Rambaud","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R16-20250514","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jclinpath-2011-200218","article-title":"Tandem mass spectrometry findings at autopsy for detection of metabolic disease in infant deaths: postmortem changes and confounding factors.","volume":"64","author":"Pryce","year":"2011","journal-title":"J Clin Pathol"},{"key":"R17-20250514","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.forsciint.2018.05.023","article-title":"A systematic review exploring the relationship between infection and sudden unexpected death between 2000 and 2016: a forensic perspective.","volume":"289","author":"Kruger","year":"2018","journal-title":"Forensic Sci Int"},{"key":"R18-20250514","doi-asserted-by":"crossref","first-page":"2050312116658909","DOI":"10.1177\/2050312116658909","article-title":"The association between varicella (chickenpox) and group A streptococcus infections in historical perspective.","volume":"4","author":"Coleman","year":"2016","journal-title":"SAGE Open Med"},{"key":"R19-20250514","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fmicb.2016.00342","article-title":"The association between invasive group A streptococcal diseases and viral respiratory tract infections.","volume":"7","author":"Herrera","year":"2016","journal-title":"Front Microbiol"},{"key":"R20-20250514","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-695X.2011.00788.x","article-title":"Invasive group A streptococcal disease and association with varicella in Germany, 1996-2009.","volume":"62","author":"Im\u00f6hl","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R21-20250514","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(22)00865-9","article-title":"Can group A streptococcus infections be influenced by viruses in the respiratory tract?","volume":"23","author":"Turner","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"R22-20250514","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/pathogens11111320","article-title":"Influenza a virus exacerbates group A streptococcus infection and thwarts anti-bacterial inflammatory responses in murine macrophages.","volume":"11","author":"Aleith","year":"2022","journal-title":"Pathogens"},{"key":"R23-20250514","doi-asserted-by":"crossref","first-page":"ofad270","DOI":"10.1093\/ofid\/ofad270","article-title":"Epidemiological impact of the pediatric live attenuated influenza vaccine (LAIV) program on group A streptococcus (GAS) infection in England.","volume":"10","author":"Sinnathamby","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"R24-20250514","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era.","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"key":"R25-20250514","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0379-0738(01)00558-8","article-title":"C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels.","volume":"124","author":"Uhlin-Hansen","year":"2001","journal-title":"Forensic Sci Int"},{"key":"R26-20250514","doi-asserted-by":"crossref","first-page":"101968","DOI":"10.1016\/j.jflm.2020.101968","article-title":"Comparison of C-reactive protein levels between antemortem serum and postmortem serum and pericardial fluid.","volume":"73","author":"Takasu","year":"2020","journal-title":"J Forensic Leg Med"},{"key":"R27-20250514","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cmi.2022.05.022","article-title":"Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes.","volume":"28","author":"Conti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"R28-20250514","first-page":"100873","article-title":"Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges.","volume":"41","author":"Abo","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"R29-20250514","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/INF.0000000000003554","article-title":"Screening for immunodeficiencies in children with invasive pneumococcal disease: six-year experience from a UK children\u2019s hospital.","volume":"41","author":"Bijker","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R30-20250514","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cid\/ciu274","article-title":"Invasive pneumococcal disease in children can reveal a primary immunodeficiency.","volume":"59","author":"Gaschignard","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:14:16Z","timestamp":1747242856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004775","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}